Biome Technologies Releases Q3 Trading Update Friday, 4th November 2011

Trading Update

Group revenues were £15.3m in the nine months to 30 September 2011 (Q3 2010: £10.3m). This reflected a 110% increase in bioplastic sales made by the UK based Biome Bioplastics, a 34% increase in sales in Stanelco RF Technologies division and a 29% increase in third party sales at the Biotec joint venture. The Group's cash position at 30 September 2011 was £3.0m (30 June 2011: £3.6m).

Bioplastics Division

Revenues in the Bioplastics Division increased from £8.5m to £12.9m in the nine months to 30 September 2011. This was comprised of revenues of £5.3m at Biome Bioplastics and £7.6m from 3^rd party sales at the Biotec joint venture in the period.

In the third quarter, Biotec revenues were £2.7m (Q3 2010: £1.7m) benefiting from further abatement of capacity constraints in the supply chain and allowing some stock build within the business. Biome Bioplastics has achieved substantial growth in 2011 compared to comparative quarters in 2010. Q3 sales were £1.7m (Q3 2010 £0.9m). We continue to expect some quarterly volatility as the market reacts to easing of supply constraints.

Stanelco RF Technologies Division

The Stanelco RF Technologies Division continues to perform in line with management expectations with revenues increasing by 34% to £2.4m in the nine months to 30 September 2011. Phasing of sales of furnaces has been skewed to H1 in 2011 and Q3 revenues were £0.6m, below the £0.8m of Q3 2010. Progress continues to be made in broadening the business reach in the industrial marketplace.

Outlook

Trading performance remains in line with the Board's expectations for the year and we are well placed to continue delivering on our strategy through the remainder of 2011 and into 2012.

Interview with Biome Technologies CEO, Paul Mines Wednesday, 7th September 2011

Biome Technologies Presents at Proactive Investors Event in London Wednesday, 7th September 2011

Biome Technologies presented its business and H1 performance at the Proactive Investors One2One Investor Forum on Wednesday 7 September held at the Chesterfield Mayfair Hotel in London.

This event was attended by sophisticated and private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists.

The Company outlined the dynamics of the rapidly growing bioplastics market and the performance of Biome Bioplastics.  The presentation made at the event can be found here.

Biome Bioplastics publishes: "Bioplastics: an important component in global sustainability" Thursday, 1st September 2011

Biome Bioplastics launches an interesting new paper, written by Chris Goodall, that explores the scientific and market drivers behind the growing bioplastics revolution.

The bioplastics market is a rapidly evolving and interesting dynamic space and we are often asked to explain what is going on and why bioplastics are an important part of building a more sustainable economy.  Chris Goodhall has now written a fascinating paper on this subject. Click here to visit the Biome Bioplastics homepage and to read his paper titled: Bioplastics: an important component in global sustainability.

Chris Goodall is one of the UK’s leading writers on energy and the environment, specialising in quantitative analysis of complex issues. After a long career in business, he has published three books on green issues since 2007, including the award winning How to Live a Low-carbon Life and  Ten Technologies to Fix Energy and Climate, which was one of the FT’s Books of the Year. He is a regular speaker at science and literary festivals and broadcasts on radio and TV. His web site, Carbon Commentary, is part of the Guardian Environment Network.

Biome Technologies Releases 2011 Interim Results Wednesday, 31st August 2011

With Group revenue up 55% to £10.4m and both the Bioplastic and RF Divisions profitable for the first time, the business moved forward significantly in the first half.  A full copy of the results can be read here.

The presentation that accompany these results can be found here.